BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  3 min read
• Biotech Bay

  Fluidigm Corporation Introduces First Integrated Fluidic Circuit Able to Perform 9,216 Simultaneous Real-Time PCR Experiments

  June 2, 2008

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company, Medarex, Inc. Release: New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  1 min read
• Drug Development

  IDM Pharma, Inc. Announces Phase 2 Follow-Up Data Showing IDM-2101 Is Well Tolerated With Positive Survival Trend In Non-Small Cell Lung Cancer Patients - Data Presented At 44th American Society of Clinical Oncology Annual Meeting Further Supports Improve

  June 2, 2008

   · 

  4 min read
• Drug Development

  Amgen Release: Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix® (panitumumab) in Combination with Standard Chemotherapy

  June 2, 2008

   · 

  1 min read
• Drug Development

  Radiation Therapy Oncology Group Study: Adding Cetuximab to Chemotherapy and Radiotherapy Leads to Improved Outcome for Lung Cancer Patients

  June 2, 2008

   · 

  1 min read
• Drug Development

  The Myelodysplastic Syndromes (MDS) Foundation Release: Data Presented at This Year’s American Society of Clinical Oncology Meeting Provide New Insights into the Treatment of Patients with Myelodysplastic Syndromes

  June 2, 2008

   · 

  1 min read
• Drug Development

  Phase III Study of Abbott Laboratories’ Investigational TriLipix(TM) in Combination With AstraZeneca Pharmaceuticals LP’s CRESTOR(R) Meets Primary Endpoints on Key Lipids

  June 2, 2008

   · 

  4 min read
• Drug Development

  Poniard Pharmaceuticals, Inc. Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer - Poster Presented at American Society of Clinical Oncology Annual

  June 2, 2008

   · 

  5 min read
• Business

  etrials Announces CFO Resignation

  June 2, 2008

   · 

  1 min read